Molecular basis for the improvement in muscle metaboreflex and mechanoreflex control in exercise-trained humans with chronic heart failure

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 307, Issue 11, 2014, Pages H1655-H1666

  Antunes Correa, Ligia M ^a   Nobre, Thais S ^a   Groehs, Raphaela V ^a   Alves, Maria Janieire N N ^a   Fernandes, Tiago ^a   Couto, Gisele K ^a   Rondon, Maria Urbana P B ^a   Oliveira, Patricia ^a   Lima, Marta ^a   Mathias, Wilson ^a   Brum, Patricia C ^a   Mady, Charles ^a   Almeida, Dirceu R ^b   Rossoni, Luciana V ^a   Oliveira, Edilamar M ^a   Middlekauff, Holly R ^c   Negrao, Carlos E ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Exercise training; Heart failure; Mechanoreflex; Metaboreflex; Muscle sympathetic nervous system

Indexed keywords

CANNABINOID 1 RECEPTOR; CYCLOOXYGENASE 2; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA; PROSTAGLANDIN E RECEPTOR 4; THROMBOXANE A2 RECEPTOR; VANILLOID RECEPTOR 1; TRPV1 PROTEIN, HUMAN; VANILLOID RECEPTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EXERCISE; FEMALE; HEART ARREST; HEART EJECTION FRACTION; HEART FAILURE; HEART INFARCTION; HEMODYNAMIC PARAMETERS; HUMAN; HUMAN TISSUE; ISOMETRIC EXERCISE; MALE; MECHANORECEPTOR; MUSCLE BIOPSY; MUSCLE MECHANOREFLEX CONTROL; MUSCLE METABOREFLEX CONTROL; MUSCLE REFLEX; MUSCLE SYMPATHETIC NERVE ACTIVITY; POSTEXERCISE CIRCULATORY ARREST; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; ADRENERGIC SYSTEM; BIOSYNTHESIS; CHRONIC DISEASE; EXERCISE TEST; HEART STROKE VOLUME; KINESIOTHERAPY; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; REFLEX;

ADULT; AGED; CHRONIC DISEASE; CYCLOOXYGENASE 2; EXERCISE TEST; EXERCISE THERAPY; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; RECEPTOR, CANNABINOID, CB1; REFLEX; SIGNAL TRANSDUCTION; STROKE VOLUME; SYMPATHETIC NERVOUS SYSTEM; TRPV CATION CHANNELS;

EID: 84913594214     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00136.2014     Document Type: Article

References (54)

1. Antunes-Correa LM, Kanamura BY, Melo RC, Nobre TS, Ueno LM, Franco FG, Roveda F, Braga AM, Rondon MU, Brum PC, Barretto AC, Middlekauff HR, Negrao CE. Exercise training improves neuro-vascular control and functional capacity in heart failure patients regardless of age. Eur J Prev Cardiol19: 822–829, 2012.
2. Antunes-Correa LM, Melo RC, Nobre TS, Ueno LM, Franco FG, Braga AM, Rondon MU, Brum PC, Barretto AC, Middlekauff HR, Negrao CE. Impact of gender on benefits of exercise training on sympathetic nerve activity and muscle blood flow in heart failure. Eur J Heart Fail12: 58–65, 2010.
3. Azevedo ER, Kubo T, Mak S, Al-Hesayen A, Schofield A, Allan R, Kelly S, Newton GE, Floras JS, Parker JD. Nonselective vs. selective beta-adrenergic receptor blockade in congestive heart failure: differential effects on sympathetic activity. Circulation104: 2194–2199, 2001.
4. Barretto AC, Santos AC, Munhoz R, Rondon MU, Franco FG, Trombetta IC, Roveda F, de Matos LN, Braga AM, Middlekauff HR, Negrao CE. Increased muscle sympathetic nerve activity predicts mortality in heart failure patients. Int J Cardiol135: 302–307, 2009.
5. Batista ML, Jr., Rosa JC, Lopes RD, Lira FS, Martins E, Jr., Yamashita AS, Brum PC, Lancha AH, Jr., Lopes AC, Seelaender M. Exercise training changes IL-10/TNF-alpha ratio in the skeletal muscle of post-MI rats. Cytokine49: 102–108, 2010.
6. Burd NA, Dickinson JM, Lemoine JK, Carroll CC, Sullivan BE, Haus JM, Jemiolo B, Trappe SW, Hughes GM, Sanders CE, Trappe TA. Effect of a cyclooxygenase-2 inhibitor on postexercise muscle protein synthesis in humans. Am J Physiol Endocrinol Metab298: E354–E361, 2010.
7. Coats AJ, Clark AL, Piepoli M, Volterrani M, Poole-Wilson PA. Symptoms and quality of life in heart failure: the muscle hypothesis. Br Heart J72: S36–39, 1994.
8. Davel AP, Fukuda LE, De Sá LL, Munhoz CD, Scavone C, Sanz-Rosa D, Cachofeiro V, Lahera V, Rossoni LV. Effects of isoproterenol treatment for 7 days on inflammatory mediators in the rat aorta. Am J Physiol Heart Circ Physiol295: H211–H219, 2008.
9. de Mello Franco FG, Santos AC, Rondon MU, Trombetta IC, Strunz C, Braga AM, Middlekauff H, Negrão CE, Pereira Barretto AC. Effects of home-based exercise training on neurovascular control in patients with heart failure. Eur J Heart Fail8: 851–855, 2006.
10. Fraga R, Franco FG, Roveda F, de Matos LN, Braga AM, Rondon MU, Rotta DR, Brum PC, Barretto AC, Middlekauff HR, Negrao CE. Exercise training reduces sympathetic nerve activity in heart failure patients treated with carvedilol. Eur J Heart Fail9: 630–636, 2007.
11. Francis GS, Cohn JN, Johnson G, Rector TS, Goldman S, Simon A. Plasma norepinephrine, plasma renin activity, and congestive heart failure. Relations to survival and the effects of therapy in V-HeFT II. The V-HeFT VA Cooperative Studies Group. Circulation87: VI40–48, 1993.
12. Garry MG. Abnormalities of the exercise pressor reflex in heart failure. Exerc Sport Sci Rev39: 167–176, 2011.
13. Gielen S, Adams V, Mobius-Winkler S, Linke A, Erbs S, Yu J, Kempf W, Schubert A, Schuler G, Hambrecht R. Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure. J Am Coll Cardiol42: 861–868, 2003.
14. Hasking GJ, Esler MD, Jennings GL, Burton D, Johns JA, Korner PI. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation73: 615–621, 1986.
15. Kaufman MP, Longhurst JC, Rybicki KJ, Wallach JH, Mitchell JH. Effects of static muscular contraction on impulse activity of groups III and IV afferents in cats. J Appl Physiol Respir Environ Exercise Physiol55: 105–112, 1983.
16. Kleiger RE, Miller JP, Bigger JT Jr., Moss AJ. Decreased heart rate variability and its association with increased mortality after acute myo-cardial infarction. Am J Cardiol59: 256–262, 1987.
17. Koba S, Xing J, Sinoway LI, Li J. Sympathetic nerve responses to muscle contraction and stretch in ischemic heart failure. Am J Physiol Heart Circ Physiol294: H311–H321, 2008.
18. Leimbach WN Jr., Wallin BG, Victor RG, Aylward PE, Sundlof G, Mark AL. Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. Circulation73: 913–919, 1986.
19. Li J, Sinoway AN, Gao Z, Maile MD, Pu M, Sinoway LI. Muscle mechanoreflex and metaboreflex responses after myocardial infarction in rats. Circulation110: 3049–3054, 2004.
20. Middlekauff HR, Chiu J, Hamilton MA, Fonarow GC, Maclellan WR, Hage A, Moriguchi J, Patel J. Cyclooxygenase products sensitize muscle mechanoreceptors in humans with heart failure. Am J Physiol Heart Circ Physiol294: H1956–H1962, 2008.
21. Middlekauff HR, Chiu J, Hamilton MA, Fonarow GC, Maclellan WR, Hage A, Moriguchi J, Patel J. Muscle mechanoreceptor sensitivity in heart failure. Am J Physiol Heart Circ Physiol287: H1937–H1943, 2004.
22. Middlekauff HR, Nitzsche EU, Hoh CK, Hamilton MA, Fonarow GC, Hage A, Moriguchi JD. Exaggerated muscle mechanoreflex control of reflex renal vasoconstriction in heart failure. J Appl Physiol90: 1714–1719, 2001.
23. Middlekauff HR, Nitzsche EU, Hoh CK, Hamilton MA, Fonarow GC, Hage A, Moriguchi JD. Exaggerated renal vasoconstriction during exercise in heart failure patients. Circulation101: 784–789, 2000.
24. Middlekauff HR, Sinoway LI. Increased mechanoreceptor stimulation explains the exaggerated exercise pressor reflex seen in heart failure. J Appl Physiol102: 492–494; discussion 496, 2007.
25. Middlekauff HR, Vigna C, Verity MA, Fonarow GC, Horwich TB, Hamilton MA, Shieh P, Tupling AR. Abnormalities of calcium handling proteins in skeletal muscle mirror those of the heart in humans with heart failure: a shared mechanism? J Card Fail18: 724–733, 2012.
26. Mitchell JH, Kaufman MP, Iwamoto GA. The exercise pressor reflex: its cardiovascular effects, afferent mechanisms, and central pathways. Annu Rev Physiol45: 229–242, 1983.
27. Moore AE, Young LE, Dixon DA. MicroRNA and AU-rich element regulation of prostaglandin synthesis. Cancer Metastasis Rev30: 419–435, 2011.
28. Morales A, Gao W, Lu J, Xing J, Li J. Muscle cyclo-oxygenase-2 pathway contributes to the exaggerated muscle mechanoreflex in rats with congestive heart failure. Exp Physiol97: 943–954, 2012.
29. Neves M, Barreto G, Boobis L, Harris R, Roschel H, Tricoli V, Ugrinowitsch C, Negrão C, Gualano B. Incidence of adverse events associated with percutaneous muscular biopsy among healthy and diseased subjects. Scand J Med Sci Sports22: 175–178, 2012.
30. O’Connor CM, Whellan DJ, Lee KL, Keteyian SJ, Cooper LS, Ellis SJ, Leifer ES, Kraus WE, Kitzman DW, Blumenthal JA, Rendall DS, Miller NH, Fleg JL, Schulman KA, McKelvie RS, Zannad F, Pina IL. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA301: 1439–1450, 2009.
31. Piepoli M, Ponikowski P, Clark AL, Banasiak W, Capucci A, Coats AJ. A neural link to explain the “muscle hypothesis” of exercise intolerance in chronic heart failure. Am Heart J137: 1050–1056, 1999.
32. Pina IL, Apstein CS, Balady GJ, Belardinelli R, Chaitman BR, Duscha BD, Fletcher BJ, Fleg JL, Myers JN, Sullivan MJ. Exercise and heart failure: a statement from the American Heart Association Committee on exercise, rehabilitation, and prevention. Circulation107: 1210 –1225, 2003.
33. Ponikowski PP, Chua TP, Francis DP, Capucci A, Coats AJ, Piepoli MF. Muscle ergoreceptor overactivity reflects deterioration in clinical status and cardiorespiratory reflex control in chronic heart failure. Circulation104: 2324–2330, 2001.
34. Ray CA, Rea RF, Clary MP, Mark AL. Muscle sympathetic nerve responses to static leg exercise. J Appl Physiol (1985)73: 1523–1529, 1992.
35. Roveda F, Middlekauff HR, Rondon MU, Reis SF, Souza M, Nastari L, Barretto AC, Krieger EM, Negrao CE. The effects of exercise training on sympathetic neural activation in advanced heart failure: a randomized controlled trial. J Am Coll Cardiol42: 854–860, 2003.
36. Rusca N, Monticelli S. MiR-146a in immunity and disease. Mol Biol Int2011: 437301, 2011.
37. Skinner JS, McLellan TH. The transition from aerobic to anaerobic metabolism. Res Q Exerc Sport51: 234–248, 1980.
38. Smith SA, Mitchell JH, Naseem RH, Garry MG. Mechanoreflex mediates the exaggerated exercise pressor reflex in heart failure. Circulation112: 2293–2300, 2005.
39. Smith SA, Williams MA, Mitchell JH, Mammen PP, Garry MG. The capsaicin-sensitive afferent neuron in skeletal muscle is abnormal in heart failure. Circulation111: 2056–2065, 2005.
40. Sterns DA, Ettinger SM, Gray KS, Whisler SK, Mosher TJ, Smith MB, Sinoway LI. Skeletal muscle metaboreceptor exercise responses are attenuated in heart failure. Circulation84: 2034–2039, 1991.
41. Tsatsanis C, Androulidaki A, Venihaki M, Margioris AN. Signalling networks regulating cyclooxygenase-2. Int J Biochem Cell Biol38: 1654–1661, 2006.
42. Ueno LM, Drager LF, Rodrigues AC, Rondon MU, Braga AM, Mathias W, Krieger EM, Barretto AC, Middlekauff HR, Lorenzi-Filho G, Negrão CE. Effects of exercise training in patients with chronic heart failure and sleep apnea. Sleep32: 637–647, 2009.
43. Ventura-Clapier R, Mettauer B, Bigard X. Beneficial effects of endurance training on cardiac and skeletal muscle energy metabolism in heart failure. Cardiovasc Res73: 10–18, 2007.
44. Wallin BG. Assessment of sympathetic mechanisms from recordings of postganglionic efferent nerve traffic. In: Cardiovascular Reflex Control in Health and Disease, edited by Hainsworth R, Mark AL. London, UK: W. B. Saunders, 1993, p. 65–93.
45. Wang HJ, Li YL, Gao L, Zucker IH, Wang W. Alteration in skeletal muscle afferents in rats with chronic heart failure. J Physiol588: 5033–5047, 2010.
46. Wang HJ, Li YL, Zucker IH, Wang W. Exercise training prevents skeletal muscle afferent sensitization in rats with chronic heart failure. Am J Physiol Regul Integr Comp Physiol302: R1260–R1270, 2012.
47. Wang HJ, Pan YX, Wang WZ, Gao L, Zimmerman MC, Zucker IH, Wang W. Exercise training prevents the exaggerated exercise pressor reflex in rats with chronic heart failure. J Appl Physiol108: 1365–1375, 2010.
48. Wenceslau CF, Davel AP, Xavier FE, Rossoni LV. Long-term ouabain treatment impairs vascular function in resistance arteries. J Vasc Res48: 316–326, 2011.
49. Williams MA, Smith SA, O’Brien DE, Mitchell JH, Garry MG. The group IV afferent neuron expresses multiple receptor alterations in car-diomyopathyic rats: evidence at the cannabinoid CB1 receptor. J Physiol586: 835–845, 2008.
50. Winston J, Toma H, Shenoy M, Pasricha PJ. Nerve growth factor regulates VR-1 mRNA levels in cultures of adult dorsal root ganglion neurons. Pain89: 181–186, 2001.
51. Xue Q, Jong B, Chen T, Schumacher MA. Transcription of rat TRPV1 utilizes a dual promoter system that is positively regulated by nerve growth factor. J Neurochem101: 212–222, 2007.
52. Yamauchi K, Kim JS, Stone AJ, Ruiz-Velasco V, Kaufman MP. Endoperoxide 4 receptors play a role in evoking the exercise pressor reflex in rats with simulated peripheral artery disease. J Physiol591: 2949–2962, 2013.
53. Zhang X, Huang J, McNaughton PA. NGF rapidly increases membrane expression of TRPV1 heat-gated ion channels. EMBO J24: 4211–4223, 2005.
54. Zucker IH, Patel KP, Schultz HD. Neurohumoral stimulation. Heart Fail Clin8: 87–99, 2012.